intake, and weight loss are recommended for patients with hypertension, hyperlipidemia, and heart disease (Amsterdam et al., 2014). Follow Up: Indicate when patient should return to clinic and provide detailed instructions indicating if the patient should return sooner than scheduled or seek attention elsewhere. Follow up 1 week if not better. If symptoms of chest pain worsen or start to radiate to Jaw or else where, seek medical attention. Call 9-1-1- and go to the ER . Do not drive.Rationale/CitationFollow up is recommended to evaluate compliance of new medication regime, as well as to inquire about potential side effects. It is also to evaluate the occurrence or absence of chest pain and to evaluate blood pressure. Once goals have been met follow ups can occure every 3to 6 months (Harskamap, Himmelrich,Lucassen & Van Weet, 2019).
ReferencesInclude at least one evidence-based peer-reviewed journal article which relates to this case. Use the correct APA 6th edition formatting.American Diabetes Association. (2019). Comprehensive medical evaluation and assessment of comorbidities: Standards of medical care in diabetes2019. Diabetes Care, 42(Supplement 1), s28-s37. doi:10.2337/dc19-S004American Heart Association. (2019). Aspirin and heart disease. Retrieved from heart.org: http:/Amsterdam, E., Wegner, N., Brindis, R., Casey, D., Ganiats, T., Holmes, D... Zieman, S. (2014). 2014 AA/ACC guidelines for the management of patients with non-st elevation acute coronary syndromes: Executive summary/ A report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. Journal of the American College of Cardiology, 64(2), 2647-2683. doi:10.1016/j: jacc.2014.09.016Clinical Pharmacist, December 2018, Vol 10, No 12, online | DOI: 10.1211/CP.2018.20205742Harskamp, R. E., Laeven, S. C., Himmelreich, J. C., Lucassen, W., & van Weert, H. (2019). Chest pain in general practice: a systematic review of prediction rules.BMJ open,9(2), e027081. Lloyd-Jones, D., Morris, P., Ballentyne, C., Kirtcher, K., Daly, D., DePalma, S... Smith, S. (2016). 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-Cholesterol lowering in the management of atherosclerotic cardiovascular disease risk: A report of the American College of Cardiologist consensus documents. Journal of the American College of Cardiology, 68(1). doi: 10.1016/j.jacc.2016.03.519
You've reached the end of your free preview.
Want to read all 14 pages?
- Fall '15